{
    "pmcid": "11140640",
    "qa_pairs": {
        "What is the primary target for vaccine development mentioned in the study due to its role in viral attachment and entry?": [
            "The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein",
            "The nucleocapsid protein of SARS-CoV-2",
            "The membrane protein of SARS-CoV-2",
            "The envelope protein of SARS-CoV-2"
        ],
        "What is the significance of epitope conservancy across different SARS-CoV-2 variants as mentioned in the study?": [
            "It may offer broad protection against multiple variants",
            "It ensures the vaccine targets only the original virus strain",
            "It reduces the need for booster vaccinations",
            "It limits the immune response to a single variant"
        ],
        "What structural feature of the RBD is highlighted as advantageous for nanobody design due to its stability?": [
            "The abundance of \u03b2-sheets",
            "The presence of \u03b1-helices",
            "The high glycosylation sites",
            "The disordered loops"
        ],
        "What type of immune response is the epitope-based vaccine design aiming to elicit according to the study?": [
            "Strong B-cell and T-cell responses",
            "Only T-cell responses",
            "Only B-cell responses",
            "Innate immune responses"
        ],
        "Which bioinformatics tool was used for creating a high-quality homology model of the RBD in the study?": [
            "MolProbity analysis",
            "BLAST",
            "Clustal Omega",
            "PyMOL"
        ]
    }
}